PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $497,989 | -1.8% | 12,428 | 0.0% | 0.00% | – |
| Q1 2023 | $507,186 | +62904.5% | 12,428 | -40.4% | 0.00% | -100.0% |
| Q4 2022 | $805 | -99.9% | 20,858 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $1,107,000 | -8.7% | 20,804 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,213,000 | -23.3% | 20,804 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,581,000 | +26.8% | 20,719 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,247,000 | +7.1% | 20,719 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,164,000 | +20.4% | 20,787 | +30.4% | 0.00% | 0.0% |
| Q2 2021 | $967,000 | -13.5% | 15,940 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $1,118,000 | +6.6% | 15,950 | -9.0% | 0.00% | 0.0% |
| Q4 2020 | $1,049,000 | +12.0% | 17,532 | +12.5% | 0.00% | 0.0% |
| Q3 2020 | $937,000 | -20.8% | 15,584 | -30.9% | 0.00% | 0.0% |
| Q2 2020 | $1,183,000 | +35.0% | 22,552 | -13.7% | 0.00% | 0.0% |
| Q1 2020 | $876,000 | -26.2% | 26,117 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $1,187,000 | +1.5% | 26,196 | -14.7% | 0.00% | 0.0% |
| Q3 2019 | $1,169,000 | +385.1% | 30,704 | +481.3% | 0.00% | – |
| Q4 2017 | $241,000 | -19.1% | 5,282 | -15.6% | 0.00% | – |
| Q2 2017 | $298,000 | +4.6% | 6,257 | 0.0% | 0.00% | – |
| Q1 2017 | $285,000 | +32.6% | 6,257 | -0.4% | 0.00% | – |
| Q3 2016 | $215,000 | -4.9% | 6,282 | +1.4% | 0.00% | – |
| Q2 2016 | $226,000 | -43.5% | 6,197 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $400,000 | -16.0% | 6,197 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $476,000 | +94.3% | 6,197 | +4.2% | 0.00% | 0.0% |
| Q3 2015 | $245,000 | -27.7% | 5,950 | +24.0% | 0.00% | 0.0% |
| Q2 2015 | $339,000 | -20.4% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $426,000 | 0.0% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $426,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |